Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.